Article Details
Retrieved on: 2022-11-01 08:41:07
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca (AZN) said its COVID-19 vaccine Vaxzevria was granted full marketing authorization ((MA)) in the EU.Vaxzevria (ChAdOx1-S [Recombinant] ...
Article found on: seekingalpha.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here